Cargando…

Prognostic Risk Factors of Carbapenem-Resistant Gram-Negative Bacteria Bloodstream Infection in Immunosuppressed Patients: A 7-Year Retrospective Cohort Study

PURPOSE: Carbapenem-resistant Gram-negative bacteria bloodstream infection (CRGNB-BSI) has gradually become a major threat worldwide due to its treatment difficulty and high mortality. This study aimed to determine the risk factors for CRGNB-BSI in immunosuppressed patients. PATIENTS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yulian, Lin, Hongxia, Xu, Yumin, Yao, Yijin, Shi, Dake, Li, Junjie, Zhu, Haixing, Summah, Hanssa Dwarka, Ni, Lei, Feng, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637366/ https://www.ncbi.nlm.nih.gov/pubmed/36349216 http://dx.doi.org/10.2147/IDR.S386342

Ejemplares similares

The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study
por: Lin, Hongxia, et al.
Publicado: (2022)

Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study
por: Lin, Hongxia, et al.
Publicado: (2022)

A Microbial World: Could Metagenomic Next-Generation Sequencing Be Involved in Acute Respiratory Failure?
por: Huang, Chunrong, et al.
Publicado: (2021)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
por: Lu, Linli, et al.
Publicado: (2022)

Susceptibility of cefiderocol and other antibiotics against carbapenem-resistant, Gram-negative bacteria
por: Wang, Yifan, et al.
Publicado: (2022)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

2302. Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Bacteria in Pediatric Intensive Care Unit (PICU): Risk Factors and Outcomes
por: Darda, Violetta-Magdalini, et al.
Publicado: (2018)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Biomarkers: A Definite Plus in Pneumonia
por: Summah, Hanssa, et al.
Publicado: (2009)

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections
por: Dambroso-Altafini, Daniela, et al.
Publicado: (2022)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
por: Davoudi-Monfared, Effat, et al.
Publicado: (2018)

Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
por: Schultze, Tilman G., et al.
Publicado: (2021)

Carbapenem Resistance in Gram-Negative Bacteria: A Hospital-Based Study in Egypt
por: Elrahem, Amira Abd, et al.
Publicado: (2023)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria, volume II
por: Daoud, Ziad, et al.
Publicado: (2023)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
por: Rivera-Villegas, Hector Orlando, et al.
Publicado: (2023)

Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection
por: Dong, Yuzhu, et al.
Publicado: (2020)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay
por: Kousouli, E., et al.
Publicado: (2019)

Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2020)

Genetic Basis of Antimicrobial Resistant Gram-Negative Bacteria Isolated From Bloodstream in Brazil
por: Silveira, Melise Chaves, et al.
Publicado: (2021)

Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic
por: Alcántar-Curiel, María Dolores, et al.
Publicado: (2023)

Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot
por: Teo, Jocelyn Qi Min, et al.
Publicado: (2016)

Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India
por: Manohar, Prasanth, et al.
Publicado: (2021)

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
por: Mancuso, Giuseppe, et al.
Publicado: (2023)

Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure
por: Zhu, Lin-Yun, et al.
Publicado: (2011)

High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction
por: Chen, Fang, et al.
Publicado: (2020)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

Comparison of bloodstream infections in intensive care unit patients, due to different Gram-negative bacteria
por: Pratikaki, M, et al.
Publicado: (2007)

Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features
por: Leal, Helena Ferreira, et al.
Publicado: (2019)

Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria
por: Lipworth, Sam, et al.
Publicado: (2022)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

Prevalence of Carbapenem Non-susceptible Gram-Negative Bacteria at Tertiary Care Hospitals in Saudi Arabia
por: Aloraifi, Rayan I, et al.
Publicado: (2023)

Emergence of carbapenem resistance in Gram-negative nosocomial bloodstream infections among critically ill children? A single-center experience
por: Sasidaran, K, et al.
Publicado: (2012)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qrd4a9jurmeq9cgh64ruaj9g4u